{"entity":{"type":"insider","cik":"0001604873","url":"/insider/0001604873","json_url":"/insider/0001604873.json","name":"SUMMER ROAD LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":17,"first":"2020-03-17","last":"2024-02-27","span_basis":"filed_date"},"name_variants":[{"name":"SUMMER ROAD LLC","source":"filing","n_filings":17,"first_seen":"2020-03-17","last_seen":"2024-02-27"}],"transactions":[{"id":3198294,"accession":"0000893838-24-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000893838-24-000022","line_url":"/filing/0000893838-24-000022#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":930851.0,"shares_display":"930,851","price_per_share":7.52,"price_display":"7.52","price_state":"stated","total_value":6999999.52,"total_display":"6,999,999.52","total_whole":"7,000,000","shares_owned_after":8591401.0,"shares_owned_after_display":"8,591,401","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-27","scope":"insider"},{"id":8061800,"accession":"0000893838-23-000086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000893838-23-000086","line_url":"/filing/0000893838-23-000086#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1538461.0,"shares_display":"1,538,461","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":4999998.25,"total_display":"4,999,998.25","total_whole":"4,999,998","shares_owned_after":7660550.0,"shares_owned_after_display":"7,660,550","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-18","scope":"insider"},{"id":6460077,"accession":"0001567619-22-019384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-019384","line_url":"/filing/0001567619-22-019384#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7328.0,"shares_display":"7,328","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":25648.0,"total_display":"25,648.00","total_whole":"25,648","shares_owned_after":6122089.0,"shares_owned_after_display":"6,122,089","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-07","filed_date":"2022-11-09","scope":"insider"},{"id":6227575,"accession":"0001567619-22-018444","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-018444","line_url":"/filing/0001567619-22-018444#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.8993,"price_display":"3.90","price_state":"stated","total_value":38993.0,"total_display":"38,993.00","total_whole":"38,993","shares_owned_after":6114761.0,"shares_owned_after_display":"6,114,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-11","filed_date":"2022-10-12","scope":"insider"},{"id":6227569,"accession":"0001567619-22-018444","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-018444","line_url":"/filing/0001567619-22-018444#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.9982,"price_display":"4.00","price_state":"stated","total_value":39982.0,"total_display":"39,982.00","total_whole":"39,982","shares_owned_after":6104761.0,"shares_owned_after_display":"6,104,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-10","filed_date":"2022-10-12","scope":"insider"},{"id":6102190,"accession":"0001567619-22-017965","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-22-017965","line_url":"/filing/0001567619-22-017965#line-3","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18800.0,"shares_display":"18,800","price_per_share":4.0419,"price_display":"4.04","price_state":"stated","total_value":75987.72,"total_display":"75,987.72","total_whole":"75,988","shares_owned_after":6094761.0,"shares_owned_after_display":"6,094,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-29","filed_date":"2022-09-29","scope":"insider"},{"id":6102187,"accession":"0001567619-22-017965","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-017965","line_url":"/filing/0001567619-22-017965#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":4.1,"price_display":"4.10","price_state":"stated","total_value":4920.0,"total_display":"4,920.00","total_whole":"4,920","shares_owned_after":6075961.0,"shares_owned_after_display":"6,075,961","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-09-29","scope":"insider"},{"id":6102179,"accession":"0001567619-22-017965","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-017965","line_url":"/filing/0001567619-22-017965#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":130000.0,"shares_display":"130,000","price_per_share":4.6794,"price_display":"4.68","price_state":"stated","total_value":608322.0,"total_display":"608,322.00","total_whole":"608,322","shares_owned_after":6074761.0,"shares_owned_after_display":"6,074,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-27","filed_date":"2022-09-29","scope":"insider"},{"id":6303952,"accession":"0001567619-22-005374","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-005374","line_url":"/filing/0001567619-22-005374#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.7986,"price_display":"4.80","price_state":"stated","total_value":47986.0,"total_display":"47,986.00","total_whole":"47,986","shares_owned_after":5944761.0,"shares_owned_after_display":"5,944,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-23","filed_date":"2022-02-23","scope":"insider"},{"id":6303949,"accession":"0001567619-22-005374","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-005374","line_url":"/filing/0001567619-22-005374#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":4.9985,"price_display":"5.00","price_state":"stated","total_value":199940.0,"total_display":"199,940.00","total_whole":"199,940","shares_owned_after":5934761.0,"shares_owned_after_display":"5,934,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-18","filed_date":"2022-02-23","scope":"insider"},{"id":6656209,"accession":"0001567619-22-002090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-002090","line_url":"/filing/0001567619-22-002090#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4023.0,"shares_display":"4,023","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":20919.6,"total_display":"20,919.60","total_whole":"20,920","shares_owned_after":5894761.0,"shares_owned_after_display":"5,894,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-28","filed_date":"2022-01-31","scope":"insider"},{"id":6656206,"accession":"0001567619-22-002090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-002090","line_url":"/filing/0001567619-22-002090#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1477.0,"shares_display":"1,477","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":7680.4,"total_display":"7,680.40","total_whole":"7,680","shares_owned_after":5890738.0,"shares_owned_after_display":"5,890,738","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-27","filed_date":"2022-01-31","scope":"insider"},{"id":6394251,"accession":"0001567619-22-001593","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-22-001593","line_url":"/filing/0001567619-22-001593#line-3","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44400.0,"shares_display":"44,400","price_per_share":5.3129,"price_display":"5.31","price_state":"stated","total_value":235892.76,"total_display":"235,892.76","total_whole":"235,893","shares_owned_after":5889261.0,"shares_owned_after_display":"5,889,261","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-24","scope":"insider"},{"id":6394248,"accession":"0001567619-22-001593","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-001593","line_url":"/filing/0001567619-22-001593#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12152.0,"shares_display":"12,152","price_per_share":5.5572,"price_display":"5.56","price_state":"stated","total_value":67531.0944,"total_display":"67,531.09","total_whole":"67,531","shares_owned_after":5844861.0,"shares_owned_after_display":"5,844,861","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-21","filed_date":"2022-01-24","scope":"insider"},{"id":6394245,"accession":"0001567619-22-001593","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-001593","line_url":"/filing/0001567619-22-001593#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17948.0,"shares_display":"17,948","price_per_share":5.7045,"price_display":"5.70","price_state":"stated","total_value":102384.366,"total_display":"102,384.37","total_whole":"102,384","shares_owned_after":5832709.0,"shares_owned_after_display":"5,832,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-20","filed_date":"2022-01-24","scope":"insider"},{"id":6160207,"accession":"0001567619-22-001260","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-22-001260","line_url":"/filing/0001567619-22-001260#line-3","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6807.0,"shares_display":"6,807","price_per_share":5.9978,"price_display":"6.00","price_state":"stated","total_value":40827.0246,"total_display":"40,827.02","total_whole":"40,827","shares_owned_after":5814761.0,"shares_owned_after_display":"5,814,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-18","scope":"insider"},{"id":6160205,"accession":"0001567619-22-001260","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-001260","line_url":"/filing/0001567619-22-001260#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33193.0,"shares_display":"33,193","price_per_share":6.0287,"price_display":"6.03","price_state":"stated","total_value":200110.6391,"total_display":"200,110.64","total_whole":"200,111","shares_owned_after":5807954.0,"shares_owned_after_display":"5,807,954","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-14","filed_date":"2022-01-18","scope":"insider"},{"id":6160201,"accession":"0001567619-22-001260","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-001260","line_url":"/filing/0001567619-22-001260#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.1983,"price_display":"6.20","price_state":"stated","total_value":61983.0,"total_display":"61,983.00","total_whole":"61,983","shares_owned_after":5774761.0,"shares_owned_after_display":"5,774,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-13","filed_date":"2022-01-18","scope":"insider"},{"id":5076789,"accession":"0001567619-21-022197","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-022197","line_url":"/filing/0001567619-21-022197#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":6.2164,"price_display":"6.22","price_state":"stated","total_value":93246.0,"total_display":"93,246.00","total_whole":"93,246","shares_owned_after":5764761.0,"shares_owned_after_display":"5,764,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-16","scope":"insider"},{"id":5076781,"accession":"0001567619-21-022197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-022197","line_url":"/filing/0001567619-21-022197#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29490.0,"shares_display":"29,490","price_per_share":6.4149,"price_display":"6.41","price_state":"stated","total_value":189175.401,"total_display":"189,175.40","total_whole":"189,175","shares_owned_after":5749761.0,"shares_owned_after_display":"5,749,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-14","filed_date":"2021-12-16","scope":"insider"},{"id":4699875,"accession":"0001567619-21-022066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-022066","line_url":"/filing/0001567619-21-022066#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10510.0,"shares_display":"10,510","price_per_share":6.4988,"price_display":"6.50","price_state":"stated","total_value":68302.388,"total_display":"68,302.39","total_whole":"68,302","shares_owned_after":5720271.0,"shares_owned_after_display":"5,720,271","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-14","scope":"insider"},{"id":4699871,"accession":"0001567619-21-022066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-022066","line_url":"/filing/0001567619-21-022066#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":6.6498,"price_display":"6.65","price_state":"stated","total_value":199494.0,"total_display":"199,494.00","total_whole":"199,494","shares_owned_after":5709761.0,"shares_owned_after_display":"5,709,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-14","scope":"insider"},{"id":4644277,"accession":"0001567619-21-021781","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-021781","line_url":"/filing/0001567619-21-021781#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5300.0,"shares_display":"5,300","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":35775.0,"total_display":"35,775.00","total_whole":"35,775","shares_owned_after":5679761.0,"shares_owned_after_display":"5,679,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-08","filed_date":"2021-12-08","scope":"insider"},{"id":4644270,"accession":"0001567619-21-021781","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-021781","line_url":"/filing/0001567619-21-021781#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55600.0,"shares_display":"55,600","price_per_share":6.13,"price_display":"6.13","price_state":"stated","total_value":340828.0,"total_display":"340,828.00","total_whole":"340,828","shares_owned_after":5674461.0,"shares_owned_after_display":"5,674,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-08","scope":"insider"},{"id":2164837,"accession":"0001567619-20-017996","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-017996","line_url":"/filing/0001567619-20-017996#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":437.0,"shares_display":"437","price_per_share":10.48,"price_display":"10.48","price_state":"stated","total_value":4579.76,"total_display":"4,579.76","total_whole":"4,580","shares_owned_after":5618861.0,"shares_owned_after_display":"5,618,861","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-16","filed_date":"2020-10-20","scope":"insider"},{"id":3029744,"accession":"0001567619-20-010898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-010898","line_url":"/filing/0001567619-20-010898#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":363636.0,"shares_display":"363,636","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":1999998.0,"total_display":"1,999,998.00","total_whole":"1,999,998","shares_owned_after":5618424.0,"shares_owned_after_display":"5,618,424","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-19","filed_date":"2020-05-21","scope":"insider"},{"id":2367077,"accession":"0001567619-20-006975","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-006975","line_url":"/filing/0001567619-20-006975#line-3","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35052.0,"shares_display":"35,052","price_per_share":4.8703,"price_display":"4.87","price_state":"stated","total_value":170713.7556,"total_display":"170,713.76","total_whole":"170,714","shares_owned_after":5254788.0,"shares_owned_after_display":"5,254,788","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-24","filed_date":"2020-03-24","scope":"insider"},{"id":2367074,"accession":"0001567619-20-006975","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-006975","line_url":"/filing/0001567619-20-006975#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":64948.0,"shares_display":"64,948","price_per_share":4.6555,"price_display":"4.66","price_state":"stated","total_value":302365.414,"total_display":"302,365.41","total_whole":"302,365","shares_owned_after":5219736.0,"shares_owned_after_display":"5,219,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-23","filed_date":"2020-03-24","scope":"insider"},{"id":2367072,"accession":"0001567619-20-006975","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-006975","line_url":"/filing/0001567619-20-006975#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9100.0,"shares_display":"9,100","price_per_share":4.5186,"price_display":"4.52","price_state":"stated","total_value":41119.26,"total_display":"41,119.26","total_whole":"41,119","shares_owned_after":5154788.0,"shares_owned_after_display":"5,154,788","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-20","filed_date":"2020-03-24","scope":"insider"},{"id":2407269,"accession":"0001567619-20-006870","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-006870","line_url":"/filing/0001567619-20-006870#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40900.0,"shares_display":"40,900","price_per_share":4.6265,"price_display":"4.63","price_state":"stated","total_value":189223.85,"total_display":"189,223.85","total_whole":"189,224","shares_owned_after":5145688.0,"shares_owned_after_display":"5,145,688","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-19","filed_date":"2020-03-20","scope":"insider"},{"id":2407263,"accession":"0001567619-20-006870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-006870","line_url":"/filing/0001567619-20-006870#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":344938.0,"shares_display":"344,938","price_per_share":4.6217,"price_display":"4.62","price_state":"stated","total_value":1594199.9546,"total_display":"1,594,199.95","total_whole":"1,594,200","shares_owned_after":5104788.0,"shares_owned_after_display":"5,104,788","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-18","filed_date":"2020-03-20","scope":"insider"},{"id":3191350,"accession":"0001567619-20-006639","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-006639","line_url":"/filing/0001567619-20-006639#line-3","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550000.0,"shares_display":"550,000","price_per_share":4.6598,"price_display":"4.66","price_state":"stated","total_value":2562890.0,"total_display":"2,562,890.00","total_whole":"2,562,890","shares_owned_after":4759850.0,"shares_owned_after_display":"4,759,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-17","scope":"insider"},{"id":3191344,"accession":"0001567619-20-006639","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-006639","line_url":"/filing/0001567619-20-006639#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":194262.0,"shares_display":"194,262","price_per_share":4.1553,"price_display":"4.16","price_state":"stated","total_value":807216.8886,"total_display":"807,216.89","total_whole":"807,217","shares_owned_after":4209850.0,"shares_owned_after_display":"4,209,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-17","scope":"insider"},{"id":3191339,"accession":"0001567619-20-006639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-006639","line_url":"/filing/0001567619-20-006639#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001604873","owner_name":"SUMMER ROAD LLC","owner_display_name":"SUMMER ROAD LLC","owner_url":"/insider/0001604873","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":210800.0,"shares_display":"210,800","price_per_share":4.6299,"price_display":"4.63","price_state":"stated","total_value":975982.92,"total_display":"975,982.92","total_whole":"975,983","shares_owned_after":4015588.0,"shares_owned_after_display":"4,015,588","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-13","filed_date":"2020-03-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":34,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":34,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":34},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001393434","name":"OCULAR THERAPEUTIX, INC","url":"/issuer/0001393434","role":"Ten percent owner","n_filings":17,"first_seen":"2020-03-17","last_seen":"2024-02-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001604873","retrieved_at":"2026-08-25T10:27:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}